A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Autor: Cozen, W., Timofeeva, M. N., Diepstra, A., Hazelett, D., Delahaye-Sourdeix, M., Edlund, C. K., Franke, L., Rostgaard, K., Van Den Berg, D. J., Cortessis, V. K., Smedby, K. E., Glaser, S. L., Westra, H. J., Robison, L. L., Mack, T. M., Ghesquieres, H., Hwang, A. E., Nieters, A., De Sanjose, S., Lightfoot, T., Becker, N., Maynadie, M., Foretova, L., Roman, E., Benavente, Y., Rand, K. A., Nathwani, B. N., Glimelius, B., Staines, A., Boffetta, P., Link, B. K., Kiemeney, L., Ansell, S. M., Bhatia, S., Strong, L. C., Galan, P., Vatten, L., Habermann, T. M., Duell, E. J., Lake, A., Veenstra, R. N., Visser, L., Liu, Y., Urayama, K. Y., Montgomery, D., Gaborieau, V., Weiss, L. M., Byrnes, G., Lathrop, M., Cocco, P., Best, T., Skol, A. D., Adami, H. O., Melbye, M., Cerhan, J. R., Gallagher, A., Taylor, G. M., Slager, S. L., Brennan, P., Coetzee, G. A., Conti, D. V., Onel, K., Jarrett, R. F., Hjalgrim, H., Van Den Berg, A., McKay, J. D.

Recent genome-wide association studies (GWAS) of Hodgkin lymphoma (HL) have identified associations with genetic variation at both HLA and non-HLA loci; however, much of heritable HL susceptibility remains unexplained. Here we perform a meta-analysis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::ec3183a3b353ef3983453e0411c24d17
https://eprints.whiterose.ac.uk/117993/1/ncomms4856.pdf

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

Autor: Cozen W; 1] USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA [2]., Timofeeva MN; 1] International Agency for Research on Cancer (IARC), 69372 Lyon, France [2] Institute of Genetics and Molecular Medicine, University of Edinburgh, EH4 2XU Edinburgh, UK [3]., Li D; 1] [2]., Diepstra A; 1] University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands [2]., Hazelett D; 1] USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA [2]., Delahaye-Sourdeix M; 1] International Agency for Research on Cancer (IARC), 69372 Lyon, France [2]., Edlund CK; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA., Franke L; University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands., Rostgaard K; Statens Serum Institut, DK-2300 Copenhagen, Denmark., Van Den Berg DJ; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA., Cortessis VK; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA., Smedby KE; Karolinska Institutet and Karolinska University Hospital, S-221 00 Stockholm, Sweden., Glaser SL; Cancer Prevention Institute of California, Fremont, California 94538, USA., Westra HJ; University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands., Robison LL; St Jude Children's Hospital, Cordova, Tennessee 38105, USA., Mack TM; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA., Ghesquieres H; Centre Léon Bérard, UMR CNRS 5239-Université Lyon 1, 69008 Lyon, France., Hwang AE; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA., Nieters A; University Medical Centre Freiburg, D-79085 Freiburg, Germany., de Sanjose S; IDIBELL Institut Català d'Oncologia, 8907 Barcelona, Spain., Lightfoot T; University of York, YO10 5DD York, UK., Becker N; German Cancer Research Centre, D-69120 Heidelberg, Germany., Maynadie M; CHU de Dijon, EA 4184, University of Burgundy, 21070 Dijon, France., Foretova L; Masaryk Memorial Cancer Institute, 656 53 Brno, Czech Republic., Roman E; University of York, YO10 5DD York, UK., Benavente Y; IDIBELL Institut Català d'Oncologia, 8907 Barcelona, Spain., Rand KA; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA., Nathwani BN; City of Hope National Medical Center, Duarte, California 91010, USA., Glimelius B; Uppsala University, 75285 Uppsala, Sweden., Staines A; School of Nursing and Human Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland., Boffetta P; Icahn School of Medicine at Mount Sinai, New York City, New York 10029-6574, USA., Link BK; University of Iowa College of Medicine, Iowa City, Iowa 52242, USA., Kiemeney L; Radboud University Nijmegen Medical Centre, 6500HB Nijmegen, The Netherlands., Ansell SM; Mayo Clinic, Rochester, Minnesota 55905, USA., Bhatia S; City of Hope National Medical Center, Duarte, California 91010, USA., Strong LC; MD Anderson Cancer Center, University of Texas, Houston, Texas 77030, USA., Galan P; INSERM U557 (UMR Inserm; INRA; CNAM, Université Paris 13), 93017 Paris, France., Vatten L; Norwegian University of Science and Technology, NO-7491 Trondheim, Norway., Habermann TM; Mayo Clinic, Rochester, Minnesota 55905, USA., Duell EJ; IDIBELL Institut Català d'Oncologia, 8907 Barcelona, Spain., Lake A; MRC University of Glasgow Centre for Virus Research, Garscube Estate, University of Glasgow, G12 8QQ Glasgow, Scotland, UK., Veenstra RN; University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands., Visser L; University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands., Liu Y; University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands., Urayama KY; Department of Human Genetics and Disease Diversity, Tokyo Medical and Dental University, Tokyo 104-0044, Japan., Montgomery D; MRC University of Glasgow Centre for Virus Research, Garscube Estate, University of Glasgow, G12 8QQ Glasgow, Scotland, UK., Gaborieau V; International Agency for Research on Cancer (IARC), 69372 Lyon, France., Weiss LM; Clarient Pathology Services, Aliso Viejo, California 92656, USA., Byrnes G; International Agency for Research on Cancer (IARC), 69372 Lyon, France., Lathrop M; Genome Quebec, Montreal, Canada H3A 0G1., Cocco P; Institute of Occupational Health, University of Cagliari, Monserrato, 09042 Cagliari, Italy., Best T; The University of Chicago, Chicago, Illinois 60637-5415, USA., Skol AD; The University of Chicago, Chicago, Illinois 60637-5415, USA., Adami HO; 1] Karolinska Institutet and Karolinska University Hospital, S-221 00 Stockholm, Sweden [2] Harvard University School of Public Health, Boston, Massachusetts 02115, USA., Melbye M; Statens Serum Institut, DK-2300 Copenhagen, Denmark., Cerhan JR; Mayo Clinic, Rochester, Minnesota 55905, USA., Gallagher A; MRC University of Glasgow Centre for Virus Research, Garscube Estate, University of Glasgow, G12 8QQ Glasgow, Scotland, UK., Taylor GM; School of Cancer Sciences, University of Manchester, St Mary's Hospital, M13 0JH Manchester, UK., Slager SL; Mayo Clinic, Rochester, Minnesota 55905, USA., Brennan P; International Agency for Research on Cancer (IARC), 69372 Lyon, France., Coetzee GA; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA., Conti DV; USC Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90089-9175, USA., Onel K; 1] The University of Chicago, Chicago, Illinois 60637-5415, USA [2]., Jarrett RF; 1] MRC University of Glasgow Centre for Virus Research, Garscube Estate, University of Glasgow, G12 8QQ Glasgow, Scotland, UK [2]., Hjalgrim H; 1] Statens Serum Institut, DK-2300 Copenhagen, Denmark [2]., van den Berg A; 1] University of Groningen, University Medical Centre Groningen, 9700 RB Groningen, The Netherlands [2]., McKay JD; 1] International Agency for Research on Cancer (IARC), 69372 Lyon, France [2].

Publikováno v: Nature communications [Nat Commun] 2014 Jun 12; Vol. 5, pp. 3856. Date of Electronic Publication: 2014 Jun 12.